Literature DB >> 3772747

6 alpha-Methylprednisolone and 6 alpha-methylprednisone plasma protein binding in humans and rabbits.

W F Ebling, R L Milsap, S J Szefler, W J Jusko.   

Abstract

The binding of 6 alpha-methylprednisolone and 6 alpha-methylprednisone to proteins of rabbit and human plasma was studied in vitro by equilibrium dialysis. Steroid binding was determined using radiolabeled compounds and HPLC analysis methods. Both methods produced equivalent results. Plasma protein binding of 6 alpha-methylprednisolone and 6 alpha-methylprednisone averaged 75-82% and was independent of steroid concentration, suggestive of low affinity, nonspecific protein binding. A positive linear correlation of the log octanol-water partition coefficient with the nonspecific binding affinities of a homologous series of steroids, including 6 alpha-methylprednisolone and 6 alpha-methylprednisone, was demonstrated. This correlation suggests that hydrophobic binding is a major determinant of nonspecific steroid-protein interactions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3772747     DOI: 10.1002/jps.2600750807

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  13 in total

1.  Fourth-generation model for corticosteroid pharmacodynamics: a model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver.

Authors:  Y N Sun; D C DuBois; R R Almon; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1998-06

2.  Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part I: Determination and Prediction of Dexamethasone and Methylprednisolone Tissue Binding in the Rat.

Authors:  Vivaswath S Ayyar; Dawei Song; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2019-06-13       Impact factor: 4.030

3.  Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part II: Sex Differences in Methylprednisolone Pharmacokinetics and Corticosterone Suppression.

Authors:  Vivaswath S Ayyar; Debra C DuBois; Toshimichi Nakamura; Richard R Almon; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2019-06-13       Impact factor: 4.030

Review 4.  Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.

Authors:  Vivaswath S Ayyar; William J Jusko
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

Review 5.  Myopia.

Authors:  Paul N Baird; Seang-Mei Saw; Carla Lanca; Jeremy A Guggenheim; Earl L Smith Iii; Xiangtian Zhou; Kyoko-Ohno Matsui; Pei-Chang Wu; Padmaja Sankaridurg; Audrey Chia; Mohamad Rosman; Ecosse L Lamoureux; Ryan Man; Mingguang He
Journal:  Nat Rev Dis Primers       Date:  2020-12-17       Impact factor: 52.329

Review 6.  Glucocorticoids pharmacology and their application in the treatment of childhood-onset systemic lupus erythematosus.

Authors:  Jianghong Deng; Nathalie E Chalhoub; Catherine M Sherwin; Caifeng Li; Hermine I Brunner
Journal:  Semin Arthritis Rheum       Date:  2019-03-16       Impact factor: 5.532

Review 7.  Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.

Authors:  David Czock; Frieder Keller; Franz Maximilian Rasche; Ulla Häussler
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

8.  Troleandomycin effects on methylprednisolone and methylprednisone interconversion and disposition in the rabbit.

Authors:  W F Ebling; S A Rich; S J Szefler; W J Jusko
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Jan-Mar       Impact factor: 2.441

9.  Effect of corticosteroid binding globulin on the pharmacokinetics of prednisolone in rats.

Authors:  H C Ko; R R Almon; W J Jusko
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

10.  Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects.

Authors:  A N Kong; E A Ludwig; R L Slaughter; P M DiStefano; J DeMasi; E Middleton; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1989-12       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.